Skip to main content
. 2021 Sep 29;10(19):4492. doi: 10.3390/jcm10194492

Table 5.

Heart rate and HRV in the Fontan patients and control subjects.

Variables Fontan Patients (n = 30) Controls (n = 30) p-Value
Heart rate, bpm 69.1 (10.4) 80.5 (6.5) <0.001
Mean NN, ms 922.0 (157.9) 771.57 (59.4) <0.001
SDNN, ms 121.8 (29.6) 152.74 (23.94) <0.001
SDANN, ms 111.9 (31.6) 133.63 (25.2) <0.001
rMSSD, ms 16.5 (10.9–33.5) 32.65 (27.4–43.7) <0.001
pNN50, ms 6.75 (2.7–13.0) 11.8 (7.2–13.2) 0.018
HRV triangular index, ms 34.5 (11.3) 45.7 (7.8) <0.001
Very low frequency (ms2) 301.6 (13.1–491.2) 491.8 (256.2–71.2) 0.030
Low frequency (ms2) 332.8 (93.4–551.2) 712.3 (538.3–1129.1) <0.001
High frequency (ms2) 140.1 (46.1–303.2) 289.0 (156.7–370) 0.019
Total power (ms2) 861.1 (1.0–1738.0) 1618.7 (957.4–2031) 0.003
Low frequency/high frequency ratio 3.5 (2.5) 4.2 (1.5) 0.190

Continuous data are presented as mean (SD) or median (Q1–Q3). Abbreviations: HRV, heart rate variability; NN, normal-to-normal interval; pNN50, percentage difference between adjacent NN intervals of >50 ms duration; rMSSD, root mean square of the differences of successive NN intervals; SDANN, standard deviation of the averages of NN intervals in all 5-min segments of the entire recording; SDNN, standard deviation of all NN intervals.